X
TMDX icon

Xponance’s Transmedics TMDX Stock Holding History

Xponance’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$314K Buy
3,161
+514
+19% +$67K ﹤0.01% 1244
2025
Q4 		$322K Buy
2,647
+35
+1% +$4.39K ﹤0.01% 1142
2025
Q3 		$293K Buy
2,612
+30
+1% +$3.51K ﹤0.01% 1170
2025
Q2 		$346K Buy
+2,582
New +$284K ﹤0.01% 1086
2024
Q4 		– Sell
-2,116
Closed -$332K – 1467
2024
Q3 		$332K Buy
2,116
+85
+4% +$13.1K ﹤0.01% 1058
2024
Q2 		$306K Buy
+2,031
New +$244K ﹤0.01% 1053

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Xponance's TMDX Position: Q1 2026 in Review

Xponance increased its Transmedics (TMDX) stake by 19% in Q1 2026, buying an estimated $67K and bringing the position to 3,161 shares worth $314K. The position accounts for ﹤0.01% of the portfolio, ranked #1244.

Xponance first reported a position in TMDX in Q2 2024 and has held it in 6 quarters since. The position peaked at $346K in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Xponance held 3,161 shares of Transmedics worth $314K as of Q1 2026.
  • Xponance bought 514 Transmedics shares in Q1 2026, an estimated $67K.
  • Transmedics made up ﹤0.01% of Xponance's portfolio in Q1 2026, its #1244 holding.
  • Xponance first reported a position in Transmedics in Q2 2024 and has held it in 6 quarters since.
  • Xponance's Transmedics position peaked at $346K in Q2 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.